Resultados de procura - Gerd-R. Burmester
- Mostrando 1 - 20 Resultados de 176
- Go to Next Page
-
1
Rheumatology 4.0: big data, wearables and diagnosis by computer por Gerd R Burmester
Publicado 2018Artigo -
2
-
3
-
4
-
5
The etiology of rheumatoid arthritis por Hans Ulrich Scherer, Thomas Häupl, Gerd R Burmester
Publicado 2020Revisão -
6
-
7
-
8
Human mononuclear phagocyte differentiation antigens. I. Patterns of antigenic expression on the surface of human monocytes and macrophages defined by monoclonal antibodies. por A. Dimitriu-Bona, Gerd R Burmester, S J Waters, Robert Winchester
Publicado 1983Artigo -
9
-
10
-
11
-
12
Analysis of distribution and severity of inflammation in patients with osteoarthitis compared to rheumatoid arthritis by ICG-enhanced fluorescence optical imaging and musculoskelet... por A. M. Glimm, S. G. Werner, Gerd R Burmester, M. Backhaus, Sarah Ohrndorf
Publicado 2015Artigo -
13
Treatment of posttraumatic and focal osteoarthritic cartilage defects of the knee with autologous polymer-based three-dimensional chondrocyte grafts: 2-year clinical results por Christian Ossendorf, Christian Kaps, Peter Kreuz, Gerd R Burmester, Michael Sittinger, Christoph Erggelet
Publicado 2007Artigo -
14
Detection of Borrelia burgdorferi by polymerase chain reaction in synovial membrane, but not in synovial fluid from patients with persisting Lyme arthritis after antibiotic therapy por Susanne Priem, Gerd R Burmester, Thomas Kamradt, Karsten Wolbart, Michael Rittig, A. Krause
Publicado 1998Artigo -
15
-
16
-
17
Adalimumab: long-term safety in 23 458 patients from global clinical trials in rheumatoid arthritis, juvenile idiopathic arthritis, ankylosing spondylitis, psoriatic arthritis, pso... por Gerd R Burmester, Remo Panaccione, Kenneth B. Gordon, M. McIlraith, Ana P. Lacerda
Publicado 2012Revisão -
18
The Diagnosis and Treatment of Sjögren’s Syndrome por Ana‐Luisa Stefanski, C. Tomiak, Uwe Pleyer, Thomas Dietrich, Gerd R Burmester, Thomas Dörner
Publicado 2017Revisão -
19
-
20
Effectiveness and safety of the interleukin 6-receptor antagonist tocilizumab after 4 and 24 weeks in patients with active rheumatoid arthritis: the first phase IIIb real-life stud... por Gerd R Burmester, Eugen Feist, H. Kellner, Jürgen Braun, Christof Iking‐Konert, Andrea Rubbert‐Roth
Publicado 2010Artigo
Ferramentas de procura:
Materias Relacionadas
Medicine
Internal medicine
Rheumatoid arthritis
Immunology
Pathology
Disease
Adverse effect
Alternative medicine
Rheumatology
Arthritis
Biology
Gastroenterology
Intensive care medicine
Physical therapy
Antibody
Placebo
Methotrexate
Adalimumab
Clinical trial
Psoriatic arthritis
Surgery
Biochemistry
Environmental health
Political science
Population
Tofacitinib
Law
Rituximab
Tocilizumab
Dermatology